Want to see NIKI full AI Analyst Report?
Total Valuation
Niki BioSolutions Inc has a market cap or net worth of $8.04M. The enterprise value is -$2.15.
Market Cap$8.04M
Enterprise Value-$2.15
Share Statistics
Niki BioSolutions Inc has 634,682 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding634,682
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Niki BioSolutions Inc’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -10.36%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-10.36%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee0.00
Profits Per Employee-688.22K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Niki BioSolutions Inc is ―. Niki BioSolutions Inc’s PEG ratio is 0.07.
PE Ratio―
PS Ratio0.00
PB Ratio0.34
Price to Fair Value0.34
Price to FCF-4.24
Price to Operating Cash Flow-1.33
PEG Ratio0.07
Income Statement
In the last 12 months, Niki BioSolutions Inc had revenue of 0.00 and earned -1.36M in profits. Earnings per share was -19.00.
Revenue0.00
Gross Profit0.00
Operating Income-1.82M
Pretax Income-1.38M
Net Income-1.36M
EBITDA-1.82M
Earnings Per Share (EPS)-19.00
Cash Flow
In the last 12 months, operating cash flow was -535.25K and capital expenditures -5.00, giving a free cash flow of -535.26K billion.
Operating Cash Flow-535.25K
Free Cash Flow-535.26K
Free Cash Flow per Share-0.84
Dividends & Yields
Niki BioSolutions Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.47
52-Week Price Change-24.81%
50-Day Moving Average8.79
200-Day Moving Average10.10
Relative Strength Index (RSI)58.74
Average Volume (3m)113.32K
Important Dates
Niki BioSolutions Inc upcoming earnings date is Sep 15, 2026, Before Open (Not Confirmed).
Last Earnings DateApr 24, 2026
Next Earnings DateSep 15, 2026
Ex-Dividend Date―
Financial Position
Niki BioSolutions Inc as a current ratio of 0.78, with Debt / Equity ratio of 14.86%
Current Ratio0.78
Quick Ratio0.78
Debt to Market Cap0.44
Net Debt to EBITDA<0.01
Interest Coverage Ratio-18.99
Taxes
In the past 12 months, Niki BioSolutions Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Niki BioSolutions Inc EV to EBITDA ratio is -4.28, with an EV/FCF ratio of -4.24.
EV to Sales0.00
EV to EBITDA-4.28
EV to Free Cash Flow-4.24
EV to Operating Cash Flow-4.24
Balance Sheet
Niki BioSolutions Inc has $3.45M in cash and marketable securities with $3.44M in debt, giving a net cash position of $9.96K billion.
Cash & Marketable Securities$3.45M
Total Debt$3.44M
Net Cash$9.96K
Net Cash Per Share$0.02
Tangible Book Value Per Share$187.59
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Niki BioSolutions Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―